AI assistant
Sending…
ARTIVION, INC. — Director's Dealing 2018
Mar 7, 2018
31684_dirs_2018-03-07_4b4166e4-f17f-45f0-92ec-3d777812cfc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2018-03-05
Reporting Person: Capps Scott B (VP, Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-05 | Common Stock | A | 4000 | — | Acquired | 135827 | Direct |
| 2018-03-05 | Common Stock | F | 607 | $19.15 | Disposed | 135220 | Direct |
Footnotes
F1: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date.
F2: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.
More from ARTIVION, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3